乙酰化
胶质瘤
免疫印迹
HDAC4型
化学
谷氨酰胺酶
泛素
HDAC1型
癌症研究
生物化学
组蛋白脱乙酰基酶
组蛋白
生物
谷氨酰胺
组蛋白甲基转移酶
氨基酸
基因
作者
Gang Xu,Jianqiang Qu,Ming Zhang
出处
期刊:Current Cancer Drug Targets
[Bentham Science]
日期:2023-10-01
卷期号:23 (9): 742-750
被引量:1
标识
DOI:10.2174/1568009623666230329123358
摘要
Background: Inhibiting cancer metabolism via glutaminase (GLS) is a promising strategy to disrupt tumor progression. However, the mechanism regarding GLS acetylation remains largely unknown. Methods: Mitochondrial protein isolation and glutaminase activity assay were used to examine GLS activity. RT-qPCR, western blot, sphere-formation, ALDH activity, and tumor-initiating assays were performed to evaluate the alteration of cell stemness. Co-IP and rescuing experiments were conducted to explore the underlying mechanisms. Results: In this study, we demonstrated that GLS acetylation is a vital post-translational modification that inhibits GLS activity in glioma. We identified GLS as deacetylated by HDAC4, a class II deacetylase. GLS acetylation stimulated the interaction between GLS and SIRT5, thereby promoting GLS ubiquitination and inhibiting GLS activity. Furthermore, GLS overexpression suppressed the stemness of glioma cells, which was rescued by the deacetylation of GLS. Conclusion: Our findings reveal a novel mechanism of GLS regulation by acetylation and ubiquitination that participate in glioma stemness.
科研通智能强力驱动
Strongly Powered by AbleSci AI